"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Novoseven Patient Information including How Should I Take
In this Article
- What is coagulation factor VIIa (Novoseven)?
- What are the possible side effects of coagulation factor VIIa (Novoseven)?
- What is the most important information I should know about coagulation factor VIIa (Novoseven)?
- What should I discuss with my healthcare provider before using coagulation factor VIIa (Novoseven)?
- How should I use coagulation factor VIIa (Novoseven)?
- What happens if I miss a dose (Novoseven)?
- What happens if I overdose (Novoseven)?
- What should I avoid while using coagulation factor VIIa (Novoseven)?
- What other drugs will affect coagulation factor VIIa (Novoseven)?
- Where can I get more information?
What should I discuss with my healthcare provider before using coagulation factor VIIa (Novoseven)?
If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using coagulation factor VIIa, tell your doctor if you have:
- coronary artery disease (hardening of the arteries);
- a history of stroke or heart attack;
- a severe injury or infection; or
- if you are allergic to mouse, hamster, or pork proteins.
FDA pregnancy category C. Coagulation factor VIIa may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether coagulation factor VIIa passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use coagulation factor VIIa (Novoseven)?
Coagulation factor VIIa is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection. You may be shown how to use your medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine.
You may need to mix coagulation factor VIIa with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not use the medication if it has changed colors or has any particles in it. Call your doctor for a new prescription.
To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Do not miss any scheduled visits to your doctor.
Carry an ID card or wear a medical alert bracelet stating that you have a bleeding disorder in case of emergency. Any doctor, dentist, or emergency medical care provider who treats you should know about your condition.
NovoSeven should be stored in the refrigerator. Do not freeze. Avoid exposing the medication to sunlight.
NovoSeven RT may be stored at cool room temperature away from moisture, heat, and light.
After mixing NovoSeven RT with a diluent, you may keep it at room temperature or in the refrigerator and use it within 3 hours. Do not freeze or store the mixture in a syringe.
Additional Novoseven Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.